GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa
27.01.2025 Case studies Mergers and acquisitions (M&A) Typical scope of services provided in an M&A transaction on the sell side Tax law Labour law, management contracts Private Equity
As a trusted legal advisor equipped to support clients throughout the entire investment lifecycle, we had the privilege of advising Maabarot Products Ltd., a company owned by Kibbutz Ma’abarot in Israel, on the sale of 100% shares in Laboratoria Natury sp. z o.o. to Farmaceutici Procemsa S.p.A. for a purchase price exceeding EUR 28 million. Laboratoria Natury specializes in the development and production of dietary supplements operating within a CDMO model.
The transaction also encompassed the repayment of financing provided to the target company by Maabarot Products Ltd. Our team was actively involved at every stage of the project, delivering comprehensive transactional support, including negotiations and the preparation of transaction documentation.
“The sale of Laboratoria Natury marks an end of one chapter for Maabarot, while simultaneously opening another, paving the way for further growth and new challenges. We have entrusted Laboratoria Natury into good hands, hoping for the company’s continued success with its new partner on board. We are delighted that once again, GESSEL law firm team comprehensively supported us during the negotiation process and closing of the transaction.” – says Yariv Grinberg, CEO of Maabarot Products Ltd.
“I just want to say thank you on behalf of all Maabarot team to Marcin, Ola and Diana from the GESSEL team. You made a tremendous work, and you were true partners throughout the whole process.” – says Rony Michaeli, VP of Business Development & Strategy of Maabarot Products Ltd.
“GESSEL’s relationship with Maabarot Products Ltd. dates to 2011, when we had the privilege of advising on the acquisition of shares in Laboratoria Natury sp. z o.o. This achievement reflects how, with the guidance of the right legal team, a smooth transition and maximum value for all stakeholders can be successfully realized. We are grateful for the trust placed in us and remain committed to leveraging our strategic vision and market expertise to deliver exceptional outcomes.” – says Marcin Macieszczak, Managing Partner, GESSEL.
Lawyers involved in the project
Marcin Macieszczak
Managing partner
Attorney-at-law
Mergers and acquisitions (M&A) | Private Equity
Adam Kraszewski
Partner
Attorney-at-law
Labour law, management contracts | Intellectual property law | Life Sciences and Health Care
Aleksandra Szyszko-Kamińska
Managing Associate
Attorney-at-law
Mergers and acquisitions (M&A)
Diana Strzałkowska-Grad
Senior Associate
Attorney-at-law
Mergers and acquisitions (M&A)
You may also like
03.12.2025
GESSEL advised Cognor Holding on a public share offering valued at PLN 300 million
GESSEL advised Cognor Holding S.A. (the “Company”), one of the largest steel product manufacturers in Poland, on a secondary public offering of new shares with a value o...
12.11.2025
GESSEL advised the LUX MED Group on the acquisition of the Mental Path Group network of psychotherapy centres
GESSEL advised LUX MED, a leading provider of private healthcare services in Poland, on the acquisition of the Mental Path network of psychotherapy centres. Pursuant to ...